Boehringer Ingelheim has cemented the potential of its idiopathic pulmonary fibrosis (IPF) drug with a second phase 3 win in a related lung disease leading the drugmaker to expand the indications it ...

COPD is a progressive lung disease with mild symptoms in the early stages that gradually worsen. Early diagnosis and treatment can help preserve lung function. People with COPD often have trouble ...

In a recent study, Mass General Brigham researchers demonstrated that through low-cost genetic samples that can be obtained ...

Chronic obstructive pulmonary disease (COPD) is a manifestation of structural violence, the process through which societies ...

The following is a summary of “NTHi killing activity is reduced in COPD patients and is associated with a differential ...

The adjusted risk for COPD was elevated among adults who identified as regular cigarette smokers before age 15 years, ...

A COLD snap due to descend on the UK this weekend could prove deadly for millions with a common health condition, a charity ...

Researchers have been trying for decades to stop the cells that damage the lung in people with pulmonary fibrosis. Now a team ...

Researchers reported that a lung MRI technique that uses inhaled gas can identify early patchy lung defects in patients with ...

Feb. 6, 2025 — Despite new medication, cystic fibrosis often leads to permanent lung damage. Researchers have discovered that the disease causes changes in the immune system early in life ...

Patients with chronic obstructive pulmonary disease, interstitial lung disease and pulmonary hypertension experience improved ...

FIBRONEER™-ILD was a double-blind, randomized, placebo-controlled trial evaluating the efficacy and safety of nerandomilast ...